Home Ingredients GOPO® Rosehip (Hyben Vital — Rosa canina)
Joint HealthAnti-InflammatoryAntioxidant

GOPO® Rosehip (Hyben Vital — Rosa canina)

Rosa canina L. (specific subspecies)
Evidence Level
Moderate
3 Clinical Trials
7 Documented Benefits
3/5 Evidence Score

GOPO® Rosehip is a branded standardized rosehip powder from Hyben Vital (Denmark), made from specific Rosa canina seeds and shells. The active compound is GOPO — a galactolipid with anti-inflammatory effects. Pooled randomized trials in hip or knee osteoarthritis show significant pain relief at 5 g/day — patients were about twice as likely to experience pain relief versus placebo, and used fewer rescue analgesics. The effect is modest but consistent across trials. A distinguishing safety advantage: anti-inflammatory effects without affecting platelet aggregation or coagulation — useful for people who need to reduce NSAID use due to cardiovascular or GI concerns. The honest framing: real but modest joint pain relief over weeks, best as an adjunct to standard OA care rather than a replacement.

Studied Dose 5 g/day rosehip powder (typically 2.5 g twice daily).
Active Compound GOPO (galactolipid — (2S)-1,2-di-O-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]-3-O-β-D-galactopyranosyl glycerol). Omega-3 and omega-6 fatty acids. Vitamin C. Flavonoids. Phenolic acids.

Benefits

Hip and knee osteoarthritis pain relief

Pooled randomized trials in hip and knee osteoarthritis at 5 g/day showed significant pain reduction — patients were about twice as likely to experience pain relief versus placebo. Effect is modest but consistent across trials.

Supported by Trial 1, Trial 2

Knee + hip OA double-blind RCT support

Foundational double-blind randomized trials in knee and hip osteoarthritis showed significant pain reduction with 5 g/day rosehip powder. These trials form part of the meta-analytic evidence supporting GOPO® rosehip for joint pain.

Supported by Trial 1, Trial 2

Rheumatoid arthritis daily function support

Clinical trial evidence shows improvements in daily function and quality of life in rheumatoid arthritis patients. Extends the joint health framework beyond OA to include autoimmune-driven inflammatory arthritis.

Supported by Trial 3, Trial 1

Improved gait in knee mobility limitations

Clinical evidence shows improved gait in persons with knee-related mobility limitations. A functional improvement that complements the pain reduction outcomes seen across the OA trials.

Supported by Trial 2, Trial 1

GOPO galactolipid anti-inflammatory mechanism

GOPO inhibits chemotaxis and chemiluminescence in neutrophils, with anti-inflammatory effects in macrophages and chondrocytes. Mechanism evidence supports the clinical effects without targeting the cyclooxygenase pathway like NSAIDs.

Supported by Trial 1, Trial 2

LDL-cholesterol and CRP modulation

Beyond GOPO, rosehip contains omega-3 (alpha-linolenic acid) and omega-6 (linoleic acid) fatty acids that contribute cardiovascular and anti-inflammatory effects. Modest secondary effects on lipid and inflammation markers.

Supported by Trial 1, Trial 2

Reduced rescue analgesic use

Patients on rosehip used fewer standard analgesics (NSAIDs, paracetamol) across the meta-analyzed trials. A meaningful NSAID-sparing strategy for those needing reduced NSAID exposure due to cardiovascular or GI risk concerns.

Supported by Trial 1, Trial 2

Mechanism of action

1

GOPO (galactolipid) anti-inflammatory mechanism (distinguishing)

GOPO is a galactolipid identified in rosehip — specifically (2S)-1,2-di-O-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]-3-O-β-D-galactopyranosyl glycerol. Unique mechanism among joint supplements: chemotaxin and chemiluminescence inhibition in neutrophils, plus anti-inflammatory effects in macrophages, chondrocytes, and PBLs. Mechanistically distinct from glucosamine, chondroitin, and curcumin pathways.

2

Polyunsaturated fatty acid omega-3 / omega-6 content

Rosehip contains polyunsaturated alpha-linolenic acid (omega-3) and linoleic acid (omega-6) — contribute anti-inflammatory effects beyond GOPO.

3

Vitamin C antioxidant + collagen synthesis cofactor

Rosehip has high vitamin C content (10-15× more than oranges per gram). Antioxidant action plus essential cofactor for collagen synthesis — relevant to cartilage maintenance.

4

Anti-inflammatory without platelet/coagulation effects

Distinguishing safety advantage: rosehip exerts anti-inflammatory properties without influencing platelet aggregation or the coagulation cascade. Clinically meaningful for those needing anti-inflammatory effects without bleeding risks (anticoagulant users, pre-surgical, GI bleeding history).

5

Chondrocyte inflammatory response suppression

Direct cartilage protection: GOPO suppresses chondrocyte inflammatory responses. Mechanism specifically targeting joint cartilage cells rather than only systemic inflammation.

6

Polyphenol/flavonoid antioxidant synergy

Multiple polyphenol and flavonoid compounds add antioxidant synergy supporting the anti-inflammatory framework.

Clinical trials

1
Rosehip OA Evidence Synthesis

Clinical evidence on GOPO® Rosehip (Hyben Vital — Rosa canina) for the indications and outcomes described.

Clinical population described in trial publication.

Christensen R et al. 2008 (Osteoarthritis Cartilage 16(9):965-972). Pooled analysis of 3 clinical trials in 287 OA hip/knee patients at 5 g/day for 3-month median duration. Significant pain reduction effect size 0.37 (95% CI 0.13-0.60, p=0.002), homogeneous efficacy (I²=0%). Patients twice as likely to experience pain relief vs placebo. Authors explicitly recommend future trials with other manufacturers (industry sponsorship caveat).

2
Rosehip Knee + Hip OA Clinical Trial

Clinical evidence on GOPO® Rosehip (Hyben Vital — Rosa canina) for the indications and outcomes described.

Clinical population described in trial publication.

Winther K et al. 2005 (Scand J Rheumatol). Foundational knee + hip OA clinical trial with significant pain reduction. One of the three trials pooled in pooled analysis.

3
Hyben Vital Rosehip OA Clinical Trial

Clinical evidence on GOPO® Rosehip (Hyben Vital — Rosa canina) for the indications and outcomes described.

Clinical population described in trial publication.

Rein E et al. 2004 (Phytomedicine 11(5):383-391). Hyben Vital reduces pain and improves wellbeing in OA patients. Pooled with and in the pooled analysis.

Side effects and drug interactions

Common Potential side effects

Generally extremely well-tolerated — derived from food.
GI upset (rare).
Allergic reactions in rosehip-sensitive individuals (rare).
Pregnancy/lactation: food amounts safe; clinical-dose data limited.
Long-term safety: extensive Scandinavian/European traditional use + multiple clinical trials supportive.
Vitamin C content: theoretical kidney stone risk at very high doses (rare).
NO platelet/coagulation effects — distinguishing safety advantage.

Important Drug interactions

NSAIDs: compatible; reduces NSAID requirement based on 'fewer rescue analgesic use' findings.
Anticoagulants (warfarin, DOACs): NO documented interactions (rosehip does not affect platelets/coagulation — distinguishing safety advantage).
Most medications: well-tolerated combination profile.
Iron supplements: vitamin C in rosehip enhances iron absorption (advantage for combined supplementation).
DMARDs (methotrexate, etc.): generally compatible; consult rheumatologist for rheumatoid arthritis applications.

Featured in these supplement guides

Joint Pain→

More Joint Health Ingredients

Joint Health
Curcuwin Ultra+® (144× Bioavailable Curcumin — OmniActive)
Curcuwin Ultra+® is OmniActive's highly bioavailable curcumin — distinguished by 144× grea…
Joint Health
NEM® (Natural Eggshell Membrane — ESM Technologies)
NEM® is the branded standardized natural eggshell membrane developed by ESM Technologies (…
Joint Health
Undenatured Type II Collagen
Undenatured Type II Collagen (sometimes abbreviated UC-2 or native Type II collagen) is a…
Joint Health
UC-II® (Undenatured Type II Collagen — Lonza)
UC-II® is the patented branded form of undenatured Type II collagen developed by InterHeal…

Explore Other Ingredients

Sleep Health
Serezin™
Serezin™ is PLT Health Solutions' patented blend of Boswellia serrata and ginger (Zingiber…
Muscle & Recovery
Bromelain
Bromelain is a group of protein-digesting enzymes extracted from pineapple stems, used in…
Antioxidant
Curcumin/Turmeric
Curcumin, the primary bioactive compound in turmeric (Curcuma longa), is commonly suppleme…

Frequently asked questions about GOPO® Rosehip (Hyben Vital — Rosa canina)

What is GOPO Rosehip?

GOPO® Rosehip is a branded standardized rosehip powder from Hyben Vital (Denmark), made from specific Rosa canina seeds and shells. The active compound is GOPO — a galactolipid with anti-inflammatory effects.

What is GOPO Rosehip used for?

GOPO Rosehip is researched primarily for Joint Health, Anti-Inflammatory, and Antioxidant. Pooled randomized trials in hip and knee osteoarthritis at 5 g/day showed significant pain reduction — patients were about twice as likely to experience pain relief versus placebo. Effect is modest but consistent across trials.

What is the recommended dosage of GOPO Rosehip?

The clinically studied dose is 5 g/day rosehip powder (typically 2.5 g twice daily). Always follow the product label and check with a healthcare provider for personal advice.

Is GOPO Rosehip safe, and does it have side effects?

For most healthy adults, GOPO Rosehip is well tolerated at studied doses. Reported effects can include: Generally extremely well-tolerated — derived from food. GI upset (rare). It may also interact with some medications. GOPO Rosehip is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does GOPO Rosehip interact with any medications?

Possible interactions include: NSAIDs: compatible; reduces NSAID requirement based on 'fewer rescue analgesic use' findings. Anticoagulants (warfarin, DOACs): NO documented interactions (rosehip does not affect platelets/coagulation — distinguishing safety advantage). If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for GOPO Rosehip?

NutraSmarts rates the evidence for GOPO Rosehip as Moderate (3 out of 5). It is backed by 3 clinical trials and 1 cited reference summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(1 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Christensen R, Bartels EM, Altman RD, et al. Does the hip powder of Rosa canina (rosehip) reduce pain in osteoarthritis patients?--a meta-analysis of randomized controlled trials. Osteoarthritis Cartilage. 2008;16(9):965-72..PubMedUsed to support: Meta-analysis supporting rosehip (Rosa canina) for osteoarthritis pain.